Citi Downgrades Catalyst Pharmaceutical Partners (CPRX) to Neutral
Citi analyst Samantha Semenkow downgraded Catalyst Pharmaceutical Partners (NASDAQ: CPRX) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
